back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,798
+17,400 vol $1.77 each |
67,400 | |
| Filed 2017-06-16 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
||
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,532
+11,600 vol $1.77 each |
90,600 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$51,330
+29,000 vol $1.77 each |
79,000 | |
| Filed 2017-03-01 Tx date 2015-07-14 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-01 Tx date 2017-02-24 |
$ACST
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$82,500
+50,000 vol $1.65 each |
50,000 | |
| Filed 2015-09-29 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Holder: Staal Consulting Inc. (Indirect Ownership)
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-29 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$129,000
+75,000 vol $1.72 each |
||
| Filed 2015-09-29 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Holder: Staal Consulting Inc. (Indirect Ownership)
|
Deferred Share Units
56 - Grant of rights
|
$129,000
+75,000 vol $1.72 each |
75,000 | |
| Filed 2015-07-20 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,000
+75,000 vol $1.72 each |
75,000 | |
| Filed 2015-07-20 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-20 Tx date 2015-07-16 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$129,000
+75,000 vol $1.72 each |
75,000 | |
| Filed 2015-07-20 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-15 Tx date 2015-07-14 |
$APO
Acasti Pharma Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-15 Tx date 2015-07-14 |
$NTB
Neptune Technologies & Bioressources Inc. |
Staal, Leendert Henderik
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|